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Abstract
Natural products are major molecules for drug discovery due to their structural diversity and their interaction with various 
biological targets, yet their clinical application is limited by poor water solubility or low lipophilicity, inappropriate molecular 
size, low dissolution rate and permeation, instability, high metabolic rate and rapid clearance. These issues can be solved by 
nanomedicine, by improving bioavailability and therapeutic efficacy. Here we review nanocarriers made of polymer or lipid 
constituents. Specifically, we describe the technological characteristics of each nanosystem, with examples of application to 
single natural constituents or plant extracts, and possible routes of administration. We report in vitro and in vivo studies and 
we conclude with the potential advantages of nanodelivery systems in terms of increased stability and solubility, improved 
biodistribution and efficacy, reduced adverse effects and toxicity.
Keywords Natural products · Nanovectors · Delivery systems · Polymeric and lipid nanosystems · Bioavailability and 
efficacy
Introduction
Natural products as isolated compounds or extracts of botan-
ical, animal and mineral origin have represented for mil-
lennia the only resource to maintain health and to cure or 
prevent human and animal diseases (Khan et al. 2012; Mehta 
et al. 2015). Currently, their role in therapy is still unques-
tionable and supported by numerous scientific evidences. 
Natural products also represent the main source of bioactive 
molecules and play a key role in innovative drug discov-
ery (Newman and Cragg 2020) thanks to their enormous 
structural and chemical variability, which is incomparable 
to that of any synthetic libraries (Cameron et al. 2011; Bilia 
et al. 2017). The extraordinary interest for natural products is 
mainly due to their capacity to modulate multiple biological 
targets, activating various signaling or functional pathways 
and producing a huge therapeutic significance especially for 
emerging multifactorial and complex diseases, such as can-
cer, cardiovascular and neurological pathologies (Rodrigues 
et al. 2016). Conversely, many natural products do not pos-
sess drug-like characteristics, and their efficacy and clinical 
use are limited because of physical and/or chemical insta-
bility, unsuitable partition coefficient (log P), unfavourable 
intrinsic dissolution rate or inappropriate molecular size. 
These unfavourable biopharmaceutical properties often 
cause low aqueous solubility, poor permeation and absorp-
tion through biological membranes and barriers, low bio-
distribution or rapid metabolism and clearance, resulting in 
drug plasma levels below the therapeutic concentration and 
reduced or annulled efficacy. A low bioavailability can be 
also related to distribution/accumulation of drugs in non-
targeted tissues and organs, leading to numerous side effects 
(Kesarwani et al. 2013; Jain & Chella 2020).
Diverse strategies have been used to optimise the bio-
availability of natural products (Dragicevic & Maibach 
2016; Jain & Chella 2020; Paroha et al. 2020; Saka et al. 
2020). They are mainly chemical strategies producing semi-
synthetic compounds or synthetic analogues (Fang & Leu 
2006; Ita 2016), but recently there is an increasing interest in 
developing appropriate formulations, specifically nanodeliv-
ery systems, which present numerous advantages in compar-
ison to conventional drug formulations, such as controlled 
release kinetics, targeted delivery, enhanced solubility and 
permeation, increased chemical and physical stability, and 
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extended shelf-life, with a consequent considerable greater 
clinic effectiveness and less side-effects (Bilia et al. 2017, 
2018, 2019b; Chamundeeswari et al. 2019).
Drug delivery systems, generally between 50 and 300 nm, 
up to 1 μm, have nanoscale dimensions ranging, in nature, 
from the size of a water molecule to the red blood cell diam-
eter, as reported in Fig. 1. Some nanosized delivery systems 
have already entered in the clinic because they can offer 
an advanced approach to optimise the therapeutic efficacy, 
targeting definite tissues and organs or crossing biological 
barriers, in addition to improve the safety profile and the 
compliance of drugs (Bilia et al. 2017, 2019b).
This review reports on recent strategies in developing 
nanodelivery systems for natural products, according to their 
classification as polymeric-based and lipid-based nanovec-
tors (Fig. 2), evidencing their characteristics, advantages 
and limitations. Specifically, polymeric-based nanocarriers 
include polymeric nanoparticles, among which nanospheres 
and nanocapsules, polymeric micelles and dendrimers, 
whereas lipid nanocarriers include solid lipid nanoparti-
cles, nanostructured lipid carriers, vesicles, nanocochleates, 
nanoscale emulsions, namely nanoemulsions and microe-
mulsions, and self-microemulsifying drug delivery systems.
This article is an abridged version of the chapter by Anna 
Rita Bilia, Vieri Piazzini, Maria Camilla Bergonzi (2020) 
Nanotechnology Applications for Natural Products Delivery. 
Sustainable Agriculture Reviews 44 (pp. 1-46). Springer, 
Cham.
Polymeric nanocarriers
Polymeric nanocarriers include nanoparticles (nanocap-
sules and nanospheres), dendrimers and polymeric micelles 
(Fig. 2), made of natural, semi-synthetic or synthetic poly-
mers, selected on the basis of their biodegradability, bio-
compatibility and surface characteristics, with the aim to 
produce novel and safe carriers having a controlled and 
targeted drug delivery. Natural polymers originate from 
bacteria, fungi, animals, plants, and are mainly represented 
by polysaccharides (principally chitosan, cellulose, alginic 
acid, carrageenan, arabic gum, pectin, starch, xanthan, gel-
lan) (Divya et al. 2018; Parhi 2020) and proteins (albumin, 
casein, gelatin, soy protein hydrolysate) (Elzoghby et al. 
2012). Synthetic polymers include poly-cyanoacrylate alkyl 
esters, polylactic acid, poly (N-vinyl pyrrolidone), polyvi-
nyl alcohol, polyglycolic acid, polylactic glycolic acid (Bilia 
et al. 2017, 2018, 2019b; Kumar et al. 2019), whereas semi-
synthetic polymers are obtained by modification of natural 
polymers with synthetic polymers or synthetic chemicals by 
different methods, such as blending, crosslinking and graft-
ing (Sithole et al. 2017).
Polymeric nanoparticles
Generally, polymeric nanoparticles consist of nanocap-
sules and nanospheres with dimensions ranging from 100 
to 500 nm. In nanocapsules the drug is loaded in the central 
Fig. 1  Nanosized drug delivery systems in the scale of nature
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cavity delimited by the polymeric membrane, whereas in 
nanospheres the drug is distributed inside the polymeric 
matrix. Nanoparticles can be used for different administra-
tion routes, including the oral and parenteral ones, and they 
can strongly increase drug bioavailability, as well as allow 
sustained release of the loaded drug or selectively cross bar-
riers, such as the blood-brain barrier (Guccione et al. 2017; 
Ahuja et al. 2020).
Specifically, nanoparticles for parenteral administra-
tion, formulated using a mixture of polymers, namely poly 
lactide-co-glycolide and monomethoxy polyethylene gly-
col, were loaded with ginkgolides and bilobalide, the active 
constituents of Ginkgo biloba L., with an encapsulation 
efficiency of about 79% and a drug loading of ca. 12 mg 
per 150 mg of polymer. The mean diameter of developed 
nanoparticles was ca. 123 nm, while the zeta potential was 
ca. -30 mV. The half-life time of the gingko compounds 
was moreover considerably increased by loading into the 
polymeric nanoparticles (Han et al. 2012).
Polymeric nanoparticles are also able to modify the 
pharmacokinetic profile of curcumin after oral administra-
tion. Nanoparticles were prepared using polylactic polyg-
lycolic acid, enhancing the relative oral bioavailability of 
curcumin by 563% compared to the unformulated curcumin. 
The increased bioavailability was due to the inhibition of 
P-gp-mediated efflux, allowing to rise permeability and 
absorption of drug in the blood stream (Xie et al. 2011).
Polymeric nanoparticles have been also evaluated for 
their capability to cross blood-brain barrier after systemic 
administration in rats. Specifically, nanoparticles based on 
poly ethylcyanoacrylate, and coated with polysorbate 80, 
were loaded with salvianolic acid B and evaluated for their 
biodistribution (Grossi et al. 2017). Salvianolic acid B rep-
resents the main constituent of Salvia miltiorrhiza L. and it 
is able to prevent nervous degeneration in numerous animal 
models with different biological mechanisms (Bonaccini 
et al. 2015), however its poor chemical stability and low 
bioavailability severely limit its therapeutic use. The study 
included intracerebral injection of nanoparticles in healthy 
rats, in order to observe the distribution of nanoparticles 
within the injected hemisphere, where they mainly interacted 
with microglial cells, probably involved in their clearance by 
phagocytosis. Nanoparticles were furthermore found to be 
no toxic by chronical administration in C57/B6 mice. The 
encapsulation efficacy of salvianolic acid B was about 99%, 
whereas the loading capacity was about 53%. The mean 
diameter of nanoparticles resulted less than 300 nm and zeta 
potential was about -8.4 mV. The nanoparticles moreover 
showed a modified release of salvianolic acid B, during 8 h 
(Grossi et al. 2017).
Fig. 2  Lipid-based nanovectors, including solid lipid nanoparticles, nanostructured lipid carriers, vesicles, nanocochleates and micro/nanoemul-
sions. Polymeric-based nanovectors, including nanospheres, nanocapsules, dendrimers and polymeric micelles. W: water, O: oil
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Recently, albumin nanoparticles, prepared using two dif-
ferent cross-linking methods, the chemical and the thermal 
one, were investigated as alternative approach to cross the 
blood-brain barrier after intravenous and intraperitoneal 
administration in healthy rats. Nanoparticles were found to 
be safe by behavioural tests on rats, including tests on loco-
motor and explorative activities, as well as on the cognitive 
function (Bergonzi et al. 2016). Also, nanoparticles did not 
induce any inflammatory reaction. In a further investiga-
tion, developed albumin nanoparticles were thereby loaded 
with the characteristic terpenoid andrographolide, the main 
active constituent of Andrographis paniculate L., whose 
properties in the neurodegenerative pathologies are well 
known (Casamonti et al. 2019a). The ability of albumin 
nanoparticles in crossing the blood-brain barrier was com-
pared with that of poly ethylcyanoacrylate nanoparticles 
(Guccione et al. 2017). The studies were carried out using 
an in vitro model of blood–brain barrier based on human 
cerebral microvascular endothelial cell line (hCMEC/D3). 
The authors found that free andrographolide did not cross 
the endothelial cell line, giving consistent results with the 
in silico studies; poly ethylcyanoacrylate nanoparticles were 
able to cross the barrier, but they provisionally disordered 
the integrity of the barrier model, whereas albumin nanopar-
ticles permeated the barrier model, preserving the integrity 
of the barrier (Guccione et al. 2017).
In a very recent study, andrographolide-loaded albumin 
nanoparticles were evaluated after parental administration 
for their distribution and pharmacological effects in brain 
using TgCRND8 mice, a mouse model of Alzheimer’s dis-
ease. The nanoparticles had mean size of about 160 nm 
and a zeta potential of about -25 mV. Encapsulation effi-
ciency was greater than 99%. Nanoparticles administered 
to TgCRND8 mice were evaluated using the step down 
inhibitory avoidance test and it was observed that nano-
particles significantly enhanced (p<0.0001) the efficacy of 
loaded drug in TgCRND8 mice, which reached comparable 
performances to those obtained in wild type mice. In the 
object recognition test, both animals treated and untreated 
with andrographolide-loaded albumin nanoparticles showed 
no deficiencies in locomotor activity, exploratory activity 
and directional movement towards objects, in addition to no 
cognitive impairments (p<0.0001). Albumin nanoparticles 
loaded with the fluorescent probe, fluorescein sodium salt, 
were traced in the brain parenchyma of TgCRND8 mice, 
after intravenous and intraperitoneal administration. In addi-
tion, the immunofluorescent analyses revealed the distribu-
tion of NAF-loaded nanoparticles both in the pE3-Aβ plaque 
surroundings and inside the pE3-Aβ plaque, evidencing their 
ability to cross the blood-brain barrier and penetrate both 
undamaged and damaged brain tissues (Bilia et al. 2019a).
Reviewed studies are some examples of the wide research 
on polymeric nanoparticles as future nanomedicines for the 
treatment of various diseases. Polymeric nanoparticles were 
found to be viable nano-sized delivery system in loading 
diverse type of natural products, such as ginkgolides, bilo-
balide, curcumin, salvianolic acid B and andrographolide, 
for oral and parenteral administration, thanks to the high bio-
compatibility of constituents, resulting a promising strategy 
for the translation in clinical therapy.
Polymeric micelles
Polymeric micelles are nanovectors, ranging from 20 to 
200 nm, formed by the aggregation of amphiphilic block 
copolymers made of hydrophobic and hydrophilic mono-
mer units. Micelles spontaneously form by self-association, 
when the concentration of the monomer unit reaches the 
critical micellar concentration, similarly to the formation of 
surfactant-based micelles (Fig. 3). Polymeric micelles are 
very versatile, stable, safe and low cost nanovectors, and 
they can be used for almost all the administration routes 
(Bilia et al. 2017, 2019b).
A study on polymeric micelles loaded with curcumin was 
carried out to evaluate the inhibition of human brain glio-
blastoma proliferation. These micelles (about 142 nm) were 
prepared with an amphiphilic block copolymer synthetized 
by esterification of polyethylene glycol 400 (hydrophilic por-
tion) and oleoyl chloride (lipophilic portion). In addition, 
their effects on regular human fibroblastic cells (HFSF-PI3) 
and adult human bone marrow stromal cells were investi-
gated. Glioblastoma cell viability was not affected by unfor-
mulated curcumin. By contrast curcumin-loaded micelles 
significantly (p < 0.001) inhibited the proliferation of glio-
blastoma, meanwhile the same dosages (20, 25, 30 and 35 
μM) of micelles did not affect regular fibroblastic cells and 
stromal cells, demonstrating a very high selectivity (Tah-
masebi Mirgani et al. 2014).
Another study focused on polymeric micelles made of 
soluplus (polymer of polyvinyl caprolactam, polyethylene 
glycol and polyvinyl acetate) and polymeric mixed micelles 
made of soluplus plus vitamin E polyethylene glycol 1000 
succinate (TPGS) in 20:1 gravimetric ratio, for the oral 
administration of silymarin. Increasing amounts of the 
active constituent (from 0.5 to 4 mg/mL) were loaded inside 
micelles. Up to 3 mg/mL, silymarin-loaded micelles main-
tained similar sizes (about 60 nm), low polydispersity index 
(≤ 0.1) and high encapsulation efficiency (> 92%). Appar-
ent solubility of silymarin in the micelles was considerably 
increased, up 6-fold, and the nanovectors eluded silymarin 
degradation in the gastrointestinal tract. The in vitro permea-
tion assay, by parallel artificial membranes mimicking the 
intestinal membrane, confirmed the enhancement of passive 
diffusion of silymarin when loaded in micelles, whereas the 
transport studies with  Caco2 cell lines, besides demonstrat-
ing that both types of micelles entered into Caco-2 cells 
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via energy-dependent mechanisms, also indicated that pol-
ymeric mixed micelles enhanced the permeability of sily-
marin compared to polymeric micelles and unformulated 
extract (Piazzini et al. 2019). In the last years, nano-sized 
micelles have obtained increasing interest for diagnosis and 
treatments of many diseases, culminated with the approval 
by the Food and Drug Administration of the first micelle 
formulation of paclitaxel for the treatment of breast, ovar-
ian and lung cancer. The lipophilic core increases the solu-
bility of poorly water-soluble molecules, such as curcumin 
and silymarin, as described in reported studies, and pro-
vides a controlled drug release, while the hydrophilic shell 
protects the encapsulated drug from the external medium, 
resulting in long circulation properties and increased drug 
bioavailability.
Dendrimers
The name “dendrimer” comes from the Greek word 
“δένδρον” (dendron), meaning “tree”. In fact, dendrimers 
are self-assembling globular structures with a central core 
surrounded by branched polymers. Their size range (from 
some nanometers up to 10-20 nm) is modulated by varying 
dendrimer generation numbers (for instance G0, G1, G2, 
Fig. 4). Different surface properties can be obtained accord-
ing to the linked functional groups. Drugs can be chemically 
linked to the superficial moieties or encapsulated into the 
internal cavities. Amine derivatives (poly(amidoamine) and 
poly(propylene imine)) are used for the preparation of den-
drimers, whereas other polymers are used to functionalise 
their surface, such as the poly-L-glutamic acid and the poly-
ethylenglycol (Bilia et al. 2017, 2019b).
Fig. 3  Polymeric micelles are formed by the aggregation of amphi-
philic block copolymers, made of hydrophobic and hydrophilic mon-
omer units. Micelles spontaneously form by self-association, when 
the concentration of the monomer unit reaches the critical micellar 
concentration (CMC), similarly to the formation of surfactant-based 
micelles
Fig. 4  Dendrimers are self-assembling nanoparticles with a central 
core surrounded by branched polymers. Their size range is modulated 
by varying dendrimer generation numbers, for instance G0, G1, G2. 
Different surface properties can be obtained according to the differ-
ent linked functional groups. Drugs can be chemically linked to the 
superficial moieties or encapsulated into the internal cavities
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Recently, dendrimers with spherical shape and about 
150 nm diameter were prepared using polyamidoamine and 
loaded with curcumin, in order to increase its solubility and 
bioavailability. The developed dendrimers had no cytotoxic 
effects in breast cancer MCF-7 cells and curcumin solubility 
was enormously increased; it was found to be up to ca. 415 
times more soluble than unformulated curcumin (Falconieri 
et al. 2017).
Dendrimers are increasingly fascinating researchers and 
they hold a promising future not only in delivery of drugs 
and phytochemical bioactive compounds, but also in diagno-
sis and management of diseases. Multistep synthesis some-
times gives low yield which can be overcome by variation of 
the chemical method of preparation. A certain cytotoxicity, 
which depends on generation to which dendrimers belong 
and on nature of functional groups on their surface, was also 
observed, but can be managed by modifications of structure 
and constituents of dendrimers (Chis et al. 2020). Overall, 
their unique properties such as nanoscale uniform size, high 
degree of branching, polyvalency, water solubility, available 
internal cavities and convenient synthesis approaches make 
them promising agents for biological and drug delivery 
applications (Sherje et al. 2018).
Lipid nanocarriers
Lipid-based nanovectors are prepared using natural and syn-
thetic fatty acids, fatty alcohols, waxes, oils and fats, steroid, 
amphipathic steroids (Bilia et al. 2019b). These nanovectors 
include nano-scale emulsions (microemulsions and nanoe-
mulsions), self-microemulsifying drug delivery systems, 
solid lipid nanoparticles, nanostructured lipid carrires and 
vesicles, which can be converted in nanocochleates (Fig. 2) 
(Bilia et al. 2019b).
Microemulsions and nanoemulsions
Microemulsions and nanoemulsions are prepared using an 
oily phase, an aqueous phase and surfactants agents (McCle-
ments et al. 2012). The resulting system is optically trans-
parent with droplets (oil in water or water in oil) of nano-
sized dimensions (10-100 nm). However, the two systems 
are significantly different (Fig. 2). In fact, nanoemulsions 
have a spontaneous propensity to separate in the two ini-
tial immiscible phases and need high energy, generally by 
a microfluidic or ultrasonic approach, to be formed (Tayeb 
at al. 2018). By contrast, microemulsions can generate 
spontaneously when all the components are mixed together 
and they are optical isotropic, homogeneous and thermody-
namically stable transparent systems (Tartaro et al. 2020). 
They can be described as oil in water emulsions, water in 
oil emulsion or biphasic bicontinuos systems (Fig. 5), (Bilia 
et al. 2017, 2019b). In many cases, self-microemulsifying 
drug delivery systems can be formulated as microemulsion 
precursors, since the latter can form as soon as they come 
in contact with the external phase (Kang et al. 2004). Very 
interesting, microemulsions and nanoemulsion can be used 
for loading isolated natural compounds or complex mixtures 
of natural products (Kumar et al. 2018), such as extracts 
and essential oils (Barradas et al. 2020). In addition, all the 
administration routes are suitable for these versatile systems 
(Bilia et al. 2017, 2019b).
An oil-in-water nanoemulsion containing capsaicin was 
formulated with olive oil (oily phase), Tween 80, Span 80 
(surfactants), ethanol (co-surfactant) and water, in order to 
treat pain and inflammatory disorders. The internal phase 
droplets had very small sizes (ca. 14 nm) and did not show 
coalescence phenomena for periods longer than 8 months, at 
4°C and 45°C. The obtained nanoemulsion was formulated 
as gel (Carbopol®) and cream (cholesterol, liquid paraffin, 
soft paraffin, cetyl alcohol and beeswax) containing 0.075% 
capsaicin. After topical application, the capsaicin-formu-
lation showed significant anti-inflammatory activity in rat 
paw oedema and high resistance to pain signals (Ghiasia 
et al. 2019).
Three microemulsions, made of Cremophor EL, leci-
thin, Tween 20 and Tween 80 as surfactants, and containing 
wheat germ oil, olive oil and vitamin E as oily phase, were 
tested in vitro for permeation evaluation of curcumin after 
oral administration, using the parallel artificial membrane 
permeability assay. The best performance, with a curcumin 
permeation of about 70%, was obtained by the formulation 
prepared with vitamin E (3.3 g/100 g), Tween 20 (53.8 g/100 
g), ethanol (6.6 g/100 g) and water (36.3 g/100 g), (Bergonzi 
et al. 2014).
Fig. 5  Microemulsions can be water (W) in oil (O), bicontinuos sys-
tems or oil in water
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Recently, Piazzini and coworkers (Piazzini et al. 2017a, 
2017b) successfully tested innovative oil-in-water nanoe-
mulsions, with droplet sizes ranging from 10 to 20 nm, in 
order to improve the oral absorption of extracts of Vitex 
agnus-castus L. and Silybum marianum L. Silybum mari-
anum L. extract (4% w/w) was formulated using Labrasol, 
Cremophor EL, Labrafil and water. Vitex agnus-castus L. 
extract (6% w/w) was instead formulated using triacetin, 
Labrasol, Cremophor EL and water. The studies extensively 
proved that nanoemulsions improved the permeation of the 
characteristic constituents of the extracts, when compared 
with the unformulated extracts.
In a further study, a microemulsion based on Labrasol, 
Cremophor EL, glycerol and water was formulated and 
loaded with green tea catechins and caffeine. The micro-
emulsions well-preserved the antioxidant properties of the 
loaded constituents and the formulation was safe for mam-
malian cells (Gupta et al. 2019).
Another microemulsion, composed of triacetin, Tween 
20, Labrasol and water, was loaded with Salicis cortex L. 
extract (40 mg/mL). Droplet sizes were about 40 nm and 
the solubility of the characteristic constituents of Salicis 
cortex L. was improved with respect to the unformulated 
extract (between 2 and 3.6 times more). In vitro tests, by 
parallel artificial membranes and Caco-2 cells, evidenced 
an enhanced permeation of Salicis cortex L. constituents 
when the extract was loaded in microemulsion (Piazzini 
et al. 2018a).
A self-microemulsifying drug delivery system, formu-
lated with castor oil, Cremophor EL and 1,2-propanediol, 
was loaded in sustained-release pellets, for the oral adminis-
tration of puerarin. The pharmacokinetic profile and the bio-
availability of loaded drug was assessed in beagle dogs. The 
absolute bioavailability of puerarin loaded in the innovative 
formulation increased 2.6-fold, when compared with that 
obtained using a conventional formulation, while the relative 
bioavailability was found to be 259.7% (Zhang et al. 2012a).
Another study was focused on two microemulsions and 
two self-microemulsifying drug delivery systems for the oral 
administration of a complex commercial blend based on car-
bon dioxide extract of Serenoa repens L. (saw palmetto). 
Stability of the formulations was assessed in simulated 
gastric and intestinal fluids. The in vitro parallel artificial 
membrane permeation assay furthermore indicated a greater 
mucosal permeation for blend based on saw palmetto extract 
formulated in the nanosystems compared to the raw com-
mercial blend or the single saw palmetto extract. Permeation 
values of developed nanoemulsions and self-microemulsi-
fying drug delivery systems were between 30% and 70% 
(Guccione et al. 2018).
Recently, an olive extract from Tuscan unripe olives 
(Olea europaea L.), characterized by oleuropein (ca. 31%), 
ligstroside (ca. 3%) and verbascoside (ca. 2.5%) was loaded 
at the concentration of 35 mg/mL in a microemulsion, for 
oral administration. The developed formulation, composed 
of Capryol 90, Cremophor EL, Transcutol and water, was 
stable at +4°C for three months. The permeability of phenol 
constituents, evaluated using the parallel artificial membrane 
permeation assay, was more than 2 times higher compared 
to that of unformulated olive extract. The transport stud-
ies carried out with Caco-2 cells moreover confirmed the 
increased permeation of the formulated extract  (Papp of 26.99 
± 0.45 ×  10-6 cm/s versus 16.14 ± 0.05 ×  10-6 cm/s for the 
unformulated extract), (Cecchi et al. 2020).
Isolated natural products (capsaicin, curcumin, puera-
rin), hydroalcoholic extracts (Vitex agnus-castus L., Sily-
bym marianum L., Salicis cortex L., Olea europaea L.) 
and carbon dioxide extracts (Serenoa repens L.) were suc-
cessfully formulated in microemulsions or nanoemulsions 
or self-microemulsifying drug delivery systems, obtaining 
increased solubility or increased permeability through arti-
ficial membranes mimicking intestinal mucosa or improved 
bioavailability. Over the last decades, nano-sized emulsions 
have been areas of study for a wide range of applications, 
from food science to cosmetics and drug delivery. In order 
to facilitate the translation of nano-sized emulsion from 
research laboratories to the pharmaceutical market, a careful 
selection of constituents must be done, with regard to safety 
concerns including hypersensitivity. The selection of bio-
compatible and approved excipients is a prerequisite for any 
future pharmaceutical application. In addition, formulation 
challenges such as ease of synthesis at large scale, storage 
and stability must be addressed in view of the therapeutic 
application (Tayeb at al. 2018; Tartaro et al. 2020).
Solid lipid nanoparticles and nanostructured lipid 
carriers
Solid lipid nanoparticles and nanostructured lipid carriers 
(Fig. 2) are colloidal systems with a lipid matrix stabilized 
by surfactants. They have dimensions ranging from 50 to 
1000 nm, and they are suitable for all the administration 
routes (Mehnert and Mäder 2012). These nanovectors are 
highly biocompatible, biodegradable, safe and very stable. 
Typically, the lipid core of solid lipid nanoparticles consists 
of glycerides, fatty acids, fatty alcohols and waxes, which 
are solid at room temperature and generally recognized as 
safe ingredients. Nanostructured lipid carriers represent an 
evolution of solid lipid nanoparticles, obtained by modifica-
tion of the lipid core structure, adding a liquid lipid at room 
temperature (Das and Chaudhury 2010). Due to the genera-
tion of an imperfect matrix, nanostructured lipid carriers 
are characterized by higher entrapment efficiency and more 
stable drug loading (Poonia et al. 2016; Bilia et al. 2019b). 
The liquid lipids are generally represented by medium chain 
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triglycerides and edible oils, including corn oil, soybean oil, 
sunflower oil, vitamin E (Tamjidi et al. 2013).
Solid lipid nanoparticles based on stearic acid, lecithin 
and Myrj 52 were loaded with curcumin and investigated for 
their efficacy in an allergic rat model of asthma by intraperi-
toneal injection. The nanovectors had dimensions of ca. 190 
nm, with 75% drug entrapment efficiency. Enhanced plas-
matic and tissue curcumin concentrations, especially in lung 
and liver, were obtained with the solid lipid nanoparticles 
when compared with unformulated curcumin. The nanovec-
tors inhibited airway hyper-responsiveness and cell infiltra-
tion, in addition to suppress the expression of interleukin-4 
and interleukin-13 (Wang et al. 2012). Since curcumin has 
a wide spectrum of biological properties, but it is poorly 
soluble in water with consequent low oral bioavailability, 
it has been also formulated in solid lipid nanoparticles for 
oral administration by Righeschi and coworkers (Righeschi 
et al. 2016), with the aim to enhance its permeation through 
gastrointestinal mucous membranes. These solid lipid nano-
particles, prepared with Compritol and GRAS ingredients, 
and loaded with curcumin, had average diameter of about 
300 nm, drug loading capacity of ca. 1.60% and drug entrap-
ment efficiency of 80%. They showed high stability over one 
month of storage at +4°C and significantly improved the 
permeation of curcumin by parallel artificial membranes.
Other interesting active molecules has been delivered by 
solid lipid nanoparticles, in order to improve their oral bio-
availability. An example is andrographolide, formulated in 
nanoparticles based on compritol 888 ATO, glyceryl mon-
ostearate, lecithin and Tween-80, with entrapment efficiency 
of about 91% and drug loading of about 3.5%. Its bioavaila-
bility and antihyperlipidemic activity were improved in com-
parison to the unformulated andrographolide, by increasing 
its solubility and stability in the intestine and by changing its 
transport mechanism (evaluated in Caco-2 cell line), (Yang 
et al. 2013). Andrographolide was also formulated in stealth 
solid lipid nanoparticles based on compritol 888 ATO and 
Brij 78, for parenteral administration and brain delivery. 
Developed nanoparticles remained unchanged in presence of 
human serum albumin and plasma, in addition to be chemi-
cally and physically stable over 1 month of storage. The abil-
ity of these nanovectors to cross the blood-brain barrier was 
assessed using parallel artificial membranes and hCMEC/
D3 cells, a well-establish in vitro model of human blood-
brain barrier, in order to predict andrographolide absorp-
tion by transcellular passive diffusion. The permeation of 
andrographolide loaded in nanoparticles was increased with 
respect to the unformulated andrographolide. Furthermore, 
after intravenous administration in healthy rats, fluorescent 
solid lipid nanoparticles were detected in brain parenchyma 
outside the vascular bed, confirming their ability in vivo to 
cross the blood-brain barrier (Graverini et al. 2018).
Silymarin, extracted from seeds of Silybum marianum L., 
has been used for decades as hepatoprotectant and, recently, 
it has been proposed for beneficial effects in type 2 diabetes 
patients. However, silymarin is poorly soluble in water, with 
limited oral bioavailability. Thus, in order to enhance its 
solubility and intestinal absorption, Piazzini and coworkers 
(Piazzini et al. 2018b) developed nanostructured lipid car-
riers using stearic acid, capryol 90 and Brij S20. Obtained 
nanovectors were stable after incubation in simulated gastric 
and intestinal fluids. Evaluation of permeability of formu-
lated silymarin, by parallel artificial membrane permeability 
assay and Caco-2 cells, evidenced an increased uptake via 
active transport mechanisms. Other authors also investigated 
nanostructured lipid carriers made of glyceryl monostea-
rate and oleic acid, for the hepatic delivery of silymarin by 
oral route. In vivo studies in rats highlighted that silymarin 
loaded in the nanovectors was absorbed through the lym-
phatic system after oral gavage and its relative bioavailabil-
ity was 2-fold higher compared to the suspension of silyma-
rin. In addition, a significant amount of silymarin reached 
the liver 2 h after the administration (Chaudhary et al. 2015).
However, the nanostructured lipid carriers can be for-
mulated also for dermal application. Nanoparticles made 
of soy lecithin, glyceryl monostearate, stearic acid, and 
medium chain triglycerides, for instance, were loaded with 
quercetin and evaluated as topical delivery system. The aver-
age particle sizes were ca. 215 nm, the drug loading was 
about 3% and the encapsulation efficiency was about 90%. 
In vitro permeation studies, using mouse skin, evidenced 
the enhanced permeation of quercetin with respect to the 
unformulated quercetin, whereas in vivo drug distribution 
experiments evidenced quercetin retention in epidermis and 
dermis (Chen-Yu et al. 2012).
Solid lipid nanocarriers were developed in the early ‘90s 
to overcome the weaknesses of traditional colloidal carri-
ers, like polymeric nanoparticles and liposomes. Reviewed 
researches deal with the formulation of natural products, 
such as curcumin, andrographolide, silymarin and querce-
tin, recognized as pharmacological active substances, but 
poorly soluble in water and with low bioavailability. The 
good biocompatibility of lipid excipients makes it possible 
to use solid lipid nanocarriers in several delivery routes, 
including parenteral, oral, and topical, as described. How-
ever, despite the increased research interests on these drug 
carriers, limited pharmaceutical products containing solid 
lipid nanoparticles are on the market. More knowledge are 
required concerning the interactions between excipients and 
biological tissues of the target sites, as well as the fate of 
solid lipid nanocarriers in the systemic distribution. Addi-
tionally, an easy production on large-scale may also advance 
the commercializing process (Mishra et al. 2018; Mu et al. 
2018; Scioli Montoto et al. 2020).
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Lipid vesicles
Vesicle preparation was firstly reported in 1965 using natural 
phospholipids. Vesicles can be obtained using amphiphilic 
molecules, represented by natural or synthetic phospholipids 
(liposomes) or non-ionic surfactants (niosomes), (Fig. 2). 
Vesicles are generally spherical with sizes ranging from 50 
nm to several microns and having a primary role in affect-
ing their biodistribution and pharmacokinetics. Cholesterol 
is commonly added as fluidizing of the bilayer, although 
it does not participate in the bilayer formation (Bilia et. 
al 2019b; Bozzuto et al. 2015). They are characterized by 
high biocompatibility and biodegradability, high versatility 
because they are suitable for all the administration routes 
and can be loaded with both hydrophilic and hydrophobic 
drugs with resulting enhanced solubility, permeability, 
stability, improved bioavailability, controlled release and 
decreased toxicity of drugs. Vesicles also present ease sur-
face modification to obtain passive or active targeting deliv-
ery or prolonged circulation and life time. Major limit is the 
possible drug leakage, due to the release from the vesicles, 
together with the low stability of the colloid (Bilia et al. 
2014a, 2014b, 2017, 2019b).
Conventional liposomes
Conventional liposomes are first-generation drug delivery 
systems but still represent extremely relevant carriers. Their 
usefulness is also related to their versatility and wide-rang-
ing use because of their flexibility in being formulated in a 
broad range of pharmaceutical dosage forms, including (col-
loidal) solutions, aerosol, semi-solid or solid forms. Accord-
ingly, many approaches of formulations have been applied 
both to isolated natural products, extracts and essential oils 
(Bilia et al. 2017, 2019b).
An in vivo study on verbascoside-loaded liposomes 
demonstrated that the liposomal formulation improved 
the chemical stability and the therapeutic performance of 
the active molecule. Liposomes, with an average diameter 
around 120 nm and 83% of encapsulation efficiency, were 
tested in two animal models of neuropathic pain and the 
performance of the liposomal verbascoside was compared 
with that of unformulated drug. Verbascoside possesses, in 
fact, various pharmacological activities for human health, 
including antioxidant, anti-inflammatory and antineoplastic 
properties in addition to numerous wound healing and neu-
roprotective properties. The paw pressure test was carried 
out administering verbascoside-loaded liposomes in chronic 
constriction injury rats by intraperitoneal injection at the 
dosage of 100 mg/kg, and presented a prolonged antihyper-
algesic effect for loaded-verbascoside in comparison to the 
free drug. The effect has onset 15 min after the injection and 
persisted for 60 min (Isacchi et al. 2016).
Naringenin is a flavonoid with diverse pharmacological 
activities. However, upon ingestion it could be degraded 
into an active aglycone by the action of certain intestinal 
bacterial enzymes and the formulation in liposomes was 
proposed to stabilize the molecule and enhance its bioavail-
ability, in addition to increase its water solubility. Developed 
liposomes had dimensions suitable for the oral route (ca. 70 
nm), whereas in vivo studies in mice showed an increased 
area under the curve, indicating a correspondent enhanced 
bioavailability (about 14-fold) of naringenin after oral 
administration. Also, studies of tissue distribution evidenced 
a predominant accumulation of liposomal naringenin in the 
liver, with respect to the free drug (Wan et al. 2017).
As conventional liposomes are at times unstable when 
exposed to endogenous chemicals and enzymes in the gas-
trointestinal environment, an interest study reports the effect 
of different pluronics (F127, F87 and P85), triblock copol-
ymers many of which approved for use as food additives 
and pharmaceutical ingredients, on vesicle membranes and, 
consequently, on their stability. Pluronic-modified liposomes 
were then loaded with curcumin. It was observed that par-
ticle sizes and polydispersity of vesicles were significantly 
decreased after adding the diverse pluronics, whereas the in 
vitro release of curcumin was slower compared to the release 
from conventional liposomes. Pluronics were also able to 
enhance thermal and pH stability of vesicles, in addition to 
significantly increase the absorption of curcumin in in vitro 
simulated gastrointestinal tract studies (Lia et al. 2018).
Untargeted liposomes loaded with anticancer drugs are 
the most successful nano-drug delivery systems trans-
lated into clinical applications, including the treatment of 
hematological cancers. Nanoliposomes for the simultane-
ous delivery of berberine chloride, antineoplastic drug, and 
tariquidar, P-gp efflux pump modulator, were formulated to 
enhance berberine chloride intracellular concentration in 
doxorubicin-resistant human erythroleukemia cells (K562/
DOXO) due to Pg-p overexpression and to contemporane-
ously reduce tariquidar toxicity. Developed nanoliposomes 
had sizes around 128 nm and good PdI (ca. 0.20) and 
ζ-potential (ca. -20 mV). The stability of nanoliposomes 
in the cell culture medium showed only a slight variance in 
average sizes, PdI and encapsulation efficiency of berberine 
chloride and tariquidar. Analysis by transmission electron 
microscopy also evidenced the ability of developed nanoli-
posomes to enter in both cell lines by receptor-mediated 
endocytosis, with significant increase in berberine chloride 
uptake by K562/DOXO cell line. Moreover, formulated 
tariquidar had less toxic effects (lower cell death by necrosis) 
than free molecule, as nanoliposomes controlled tariquidar 
release, with a potential benefit in clinical therapy (Vanti 
et al. 2021b).
Nanoliposomes were also investigated to formulate the 
Serenoa repens L. (saw palmetto) carbon dioxide  (CO2) 
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extract, complex mixture constituted of free fatty acids, 
sterols, phosphoglycerides, glycerides and carotenoids. The 
saw palmetto  CO2 extract has many biological properties, 
including anti-inflammation, anti-androgen and anti-prolifer-
ation activities, and it has been recently studied for the treat-
ment of hair loss because of the inhibition of 5α-reductase 
enzyme, responsible of the conversion of testosterone to 
5α-dihydrotestosterone. Nanoliposomes (ca. 145 nm) loaded 
with 0.1% w/v of saw palmetto  CO2 extract were developed 
and fully characterized, in terms of Size, PdI, ζ-potential, 
morphology and encapsulation efficiency, for topical appli-
cation (Vanti et al. 2021a).
Some studies have also evidenced the possibility to load 
essential oils inside liposomes. Generally, essential oils are 
complex mixtures of volatile, liquid, odorous, flavor and 
strongly active compounds. Due to their various biological 
properties, principally antioxidant and antimicrobial, they 
have been widely used since the Middle Ages and currently 
they also may have several applications in different fields, 
from medicine and cosmetics to food. However, their high 
volatility and low stability to direct exposure to light, oxy-
gen, heat, and humidity can limit their efficacy and potential 
use. Accordingly, nanocarriers which can definitely load the 
essential oils, represent an innovative challenge to optimise 
the essential oil formulation, overcoming these main limita-
tions (Bilia et al. 2014a; De Matos et al. 2019). The resulting 
nanocarriers are stable and efficient, easily and safely pro-
duced, capable of stabilizing the essential oil, modulating its 
release, optimising its activity and providing an innovative 
formulative approach to avoid irritancy in case of cutaneous 
administration (Bilia et al. 2019b).
The essential oil of Artemisia annua L. was loaded in 
conventional liposomes and its anti-fungal activity was 
evaluated against 10 different drug-resistant Candida strains. 
Formulated liposomes, containing 10 mg/mL of essential 
oil, had sizes around 250 nm, whereas the encapsulation 
efficiency of artemisia ketone, the marker constituent of the 
essential oil, was ca. 75%. The minimum fungicidal concen-
tration of Artemisia annua essential oil loaded in liposomes, 
ranging 5 to 10 mg/mL, was much inferior than that of free 
essential oil (Risaliti et al. 2020b). Another study investi-
gated the antioxidant, anti-inflammatory and antibacterial 
properties of Salvia triloba L. and Rosmarinus officinalis 
L. essential oils formulated in liposomes. The obtained sys-
tems, loaded with 100 mg/mL of Salvia triloba L. or Ros-
marinus officinalis L. essential oil, presented encapsulation 
efficiency of camphor, the marker constituent, around 57% 
for Salvia triloba L. and around 65% for Rosmarinus offici-
nalis L. Liposomes were physically stable over time, when 
stored at +4°C, and very active against Klebsiella pneumo-
niae (Risaliti et al. 2019). Specifically, liposomes enhanced 
the antibacterial activity of both essential oils. Their anti-
oxidant and anti-inflammatory activities, evaluated by in 
vitro tests, were also increased in comparison to those of 
unformulated essential oils.
Pegylated liposomes
Surface functionalization of liposomes has played an impor-
tant role in formulation of liposomes as pharmaceutical car-
ries, to improve their pharmacokinetics and effectiveness. 
For instance, conventional liposomes, when administered 
intravenously, are recognized by opsonin, a serum-protein, 
and phagocyted in the reticuloendothelial system. In order 
to increase the circulation time of liposomes, the bilayer 
surface can be coated with a hydrophilic polymer, such as 
the polyethylene glycol, increasing repulsive forces between 
liposomes and serum-components. Such surface modi-
fied liposomes have been defined as pegylated or stealth 
liposomes (Riaz et al. 2018).
Therefore, in a further study, pegylated liposomes, loaded 
with salvianolic acid B, were developed and tested in the 
same animal model of neuropathic pain reported for verbas-
coside (Isacchi et al. 2016). Salvianolic acid B was effective 
against mechanical hyperalgesia 15 min after administra-
tion, when injected intraperitoneally at a dose of 100 mg/
kg. The antihyperalgesic activity prolonged for 30 min after 
administration, and the effect was still significant after 45 
min (Isacchi et al. 2011b).
Some studies report instead on the performance of con-
ventional and long circulating liposomes (pegylated) loaded 
with artemisinin, a sesquiterpene lactone isolated from the 
Artemisia annua L., well known as very active antimalarial 
drug. Conventional and long circulating liposomes, with 
sizes of 130–140 nm and encapsulation efficacy higher than 
70%, were injected in healthy mice. Free artemisinin was 
quickly cleared from plasma and it was almost not more 
detectable 1 hour after the injection. By contrast, artemisinin 
was still detectable after 3 and 24 hours when formulated 
in conventional or pegylated liposomes, respectively. The 
area under the curve (0-24 h) was six times increased with 
respect to free artemisinin. In particular, artemisinin half-
life was enhanced more than 5-fold with long circulat-
ing liposomes (Isacchi et al. 2011a). The same liposomes 
were tested in Plasmodium berghei NK-65 infected mice, 
a successful malaria model, at the dose of 50 mg/kg/day 
for artemisinin and 100 mg/kg/day for artemisinin plus cur-
cumin. In mice treated with artemisinin-loaded liposomes or 
artemisinin plus curcumin-loaded liposomes (conventional 
and pegylated) was observed an immediate antimalarian 
effect. Particularly, artemisinin-loaded long circulating 
liposomes showed the most conspicuous and statistically 
significant activity (Isacchi et al. 2012). As artemisinin 
attracted increasing interest over years also for its antitumor 
properties in a variety of cancer cells, in a further study 
it was loaded in long circulating liposomes decorated with 
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transferrin, in order to increase the up-take in tumoral cells. 
Specifically, cell uptake and cytotoxicity of liposomes were 
explored using the human colon carcinoma (HCT-8) cell 
line, because of the overexpression of transferrin receptors. 
An improved delivery of artemisinin was found for transfer-
rin decorated liposomes with respect to the long-circulating 
vesicles, and enhanced cytotoxicity was also observed due to 
iron ions, obtaining a synergic anticancer effect (Leto et al. 
2016).
Conventional and pegylated liposomes were also loaded 
with dihydroartemisinin, the natural metabolite of arte-
misinin and one of the most potent anticancer compounds, 
able to induce cancer cell death by apoptotic pathways. Cel-
lular uptake efficiency of liposomes was determined by flow 
cytometry in MCF-7 cells. Higher internalization occurred 
for conventional liposomes rather than for stealth liposomes, 
probably due to the hydrophilic steric barrier of polyethylene 
glycol molecules. Furthermore, cytotoxicity studies on these 
cancer cells evidenced an increased toxicity for the formu-
lated dihydroartemisinin and absence of toxicity for blank 
formulations (Righeschi et al. 2014).
Stabilized nanovesicles
Liposomes mostly consist of phospholipids and cholesterol. 
However, some solvents (ethanol, glycerol, propylene gly-
col) can impart stability, deformability or elasticity to the 
bilayer membrane of liposomes, resulting in a considerable 
improved drug loading and permeability through biological 
barriers by several orders of magnitude (Carita et al. 2018; 
Fernández-García et al. 2019).
Glycerosomes are innovative liposomes for dermal and 
transdermal drug delivery, based on glycerol and charac-
terized by high physical stability and excellent deformabil-
ity (Manca et al. 2013). In a recent investigation Melissa 
officinalis L. essential oil was loaded inside glycerosomes 
containing 10% v/v of glycerol, and it was evaluated for its 
anti-herpetic activity against herpes simplex virus (HSV) 
type 1 (herpes labialis). The encapsulation efficiency of the 
essential oil in terms of citral and β-caryophyllene, major 
constituents, was found to be ca. 63% and 76%, respectively. 
Moreover, the developed glycerosomes loaded with Melissa 
officinalis L. essential oil showed extraordinary chemical 
and physical stability during 4 months of storage, and were 
very active in inhibiting HSV type 1 infection of mamma-
lian cells in vitro, without producing cytotoxic effects (Vanti 
et al. 2020a).
Glycerosomes and propylene glycol-nanovesicles loaded 
with essential oils of Origanum onites L. and Satureja thym-
bra L. were also investigated as safe and food-grade delivery 
systems. Essential oils represent in fact a valid alternative 
to synthetic preservatives in the food industry. However, in 
many cases their organoleptic impact in foodstuffs limits 
their usage, in addition to the high volatility and chemical 
instability which decrease their efficacy. Techniques such as 
the encapsulation in nanodelivery systems can address this 
problem. Both pure and formulated essential oils were eval-
uated against different food-borne pathogens and spoilage 
microorganisms. Propylene glycol‐nanovesicles loaded with 
Origanum onites L. essential oil were found to be the most 
active formulation against all tested strains. Additionally, in 
vitro studies on HaCaT cell line showed that nanovesicles 
loaded with the essential oils had no toxic effect. Overall, 
these studies unveiled that tested nanovesicles could repre-
sent potential biocontrol agents against fungal and bacterial 
food pathogens with promising GRAS status in mammalian 
systems, besides being an innovative and completely biode-
gradable approach for the prolonged and sustained release 
of the essential oils, preserving functional properties (Vanti 
et al. 2021c).
Active nanovesicular carriers
Recently, innovative nanovesicular systems, escinosomes 
and ascosomes, were also investigated using natural bioac-
tive molecules as vesicle bilayer components, and they were 
studied for the skin delivery of selected model drugs.
The first study was design to explore the conversion of 
the bioactive amphiphilic saponin escin, isolated from seeds 
of Aesculus hippocastanum L. and clinically used for its 
anti-inflammatory, anti-oedematous and venotonic proper-
ties, into vesicle bilayer forming component, because of the 
suited chemical structure and the fluidizing effect on phos-
pholipid membranes. Escinosomes, the obtained nanovesi-
cles made of phosphatidylcholine plus escin, retained escin 
inhibitory activity on hyaluronidase and were subsequently 
loaded with berberine chloride, salt of the natural quaternary 
isoquinoline alkaloid berberine isolated from several medici-
nal plants. Berberine chloride was selected as model drug of 
low skin absorption. Empty and berberine chloride-loaded 
escinosomes displayed optimal characteristics for skin deliv-
ery, with high deformability, optimal physical stability, good 
encapsulation efficiency of berberine chloride (about 67%) 
and proper release rate of drug (about 75% after 24 h), (Vanti 
et al. 2019). Subsequently, escinosomes were gelled using 
hydroxypropyl methylcellulose. Developed escinosome-
hydrogels combined the benefits of a controlled release and 
improved transdermal permeability of both escin and ber-
berine chloride, thanks to the escinosome components, with 
optimised viscosity properties thanks to the polysaccharide 
matrix. The escinosome-hydrogels also showed a very good 
safety profile with no potential skin irritation, evaluated by 
in vivo acute dermal irritation/corrosion test on Sprague-
Dawley rats (Vanti et al. 2020b).
Ascosomes represent a further innovative nanocarrier 
for cutaneous application made of phosphatidylcholine plus 
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derivates of L-ascorbyl acid, ascorbyl octanoate or ascorbyl 
decanoate, investigated as bioactive constituents of the 
vesicle bilayer. L-ascorbic acid (vitamin C) plays in fact an 
important role in the prevention and treatment of a large 
number of chronic diseases, including skin disorders, but 
it hardly penetrate the stratum corneum. The synthesis of 
amphiphilic derivates is a promising approach to enhance its 
skin penetration. In addition, because of their amphiphilic 
nature, ascorbyl derivates form supramolecular assemblies 
in aqueous dispersions, and they have been investigated as 
potential constituents for drug delivery systems. Obtained 
nanovesicles, ascosomes, were thus investigated as poten-
tial nanocarriers for the skin delivery of khellin, a natural 
furanochromone with various applications in skin patholo-
gies and selected as model lipophilic drug. Developed 
ascosomes increased the cutaneous absorption of khellin and 
retained the antioxidant properties of ascorbic acid (Risaliti 
et al. 2020a). Subsequently, a hydrogel of khellin-loaded 
ascosomes was developed using hydroxyethyl cellulose, in 
order to overcome the short residence time of the liquid for-
mulation upon application on the skin, and to enhance the 
stability of the vesicles preventing their aggregation. The 
hydrogel of khellin-loaded ascosomes demonstrated a good 
safety profile in rats by the acute dermal irritation/corrosion 
test. Liver and dermal histological and pathological analy-
ses also indicated that khellin formulated in the ascosome-
hydrogel had no toxic effects (Risaliti et al. 2021).
Perspectives of lipid vesicles
The development of vesicles as carriers for therapeutic 
molecules is an ever-growing research area. Conventional 
liposomes, stabilized nanovesicles (glycerosomes and pro-
pylene glycol-nanovesicles), active nanovesicular carriers 
(escinosomes and ascosomes) have shown excellent potential 
in (co-)delivering natural products which belong to different 
chemical classes, namely phenylpropanoids (verbascoside, 
curcumin), flavonoids (naringenin), sesquiterpene lactones 
(artemisinin), saponins (escin), alkaloids (berberine chlo-
ride), furanochromones (khellin), or carbon dioxide extracts 
(Serenoa repens L.) and essential oils (Artemisia annua L., 
Salvia triloba L., Rosmarinus officinalis L., Melissa offici-
nalis L., Origanum onites L., Satureja thymbra L.). All these 
vesicular systems, besides being biocompatible and suitable 
for all the administration routes, demonstrated to improve 
the biopharmaceutical properties of loaded natural drugs or 
to increase their chemical stability, with the aim of reach-
ing an effective pharmacological activity. Lipid vesicles are 
still the most widely studied colloidal drug delivery systems, 
which also find great application in the clinical practice.
Nanocochleates
Nanocochleates represent an alternative platform to vesicles 
in order to overcome their main limitations, such as possi-
ble drug leakage, due to release processes, and low stability 
of the colloid in biological fluids. Cochleates were firstly 
observed when phosphatidylserine liposomes were treated 
with divalent metal cations, mainly magnesium and calcium. 
They are characterized by an exceptional stability due to 
their cylindrical shape and distinctive multi-layered structure 
(Fig. 2) (Bozó et al. 2017; Tilawat & Bonde 2021) and they 
were studied to formulate different kind of natural products.
Thymus vulgaris L. essential oil was loaded in nanococh-
leates (1 mg/mL), obtaining an encapsulation efficiency of 
the major constituents, thymol and carvacrol, of about 46% 
and 51%, respectively. Developed nanocochleates, ranging 
from ca. 210 to 250 nm, preserved the strong antioxidant 
activity of the unformulated Thymus vulgaris essential oil 
and were found to be suitable to provide a practical dosage 
form (Asprea et al. 2017). Nanocochleates have been also 
investigated as delivery systems of andrographolide, exten-
sively studied for its wide spectrum of biological activities 
and selected as model drug because of its low water solu-
bility and gastrointestinal instability. The developed andro-
grapholide-loaded nanocochleates were found to be stable 
after lyophilisation and resuspension in distilled water, as 
well as after incubation in simulated gastric and intestinal 
media. They also demonstrated an elevated safety profile 
both in macrophages and 3T3 fibroblasts even at high con-
centrations, in addition to extraordinary uptake properties 
in macrophages, evaluated by a fluorescent probe (Asprea 
et al. 2019).
Nanocochleate is an extremely biocompatible system 
with excellent stability due to the unique compact structure, 
gaining increasing interest in pharmaceutical research as 
nanocarrier.
Conclusion
There is an increasing interest for nano-drug delivery sys-
tems for their potential application in clinic, both for local 
and systemic administration of drugs. Concurrently, natu-
ral products, which include a large and diverse group of 
substances from various natural sources, have assumed an 
exceptional importance for the prevention and cure of many 
diseases. This is due to their unique structure and their pleio-
tropic effects by targeting and modulating multiple path-
ways. For these reasons, natural products could represent 
the ideal drugs to a realistic approach of many diseases, 
especially those with emerging resistance to monofunctional 
agents, and they are suitable approaches against multifacto-
rial and complex diseases, especially cancer and diabetes. 
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By contrast, natural products suffer of many limitations and 
the majority of constituents are not “drug like”. Accordingly, 
the various nanovectors have been attempted as potential 
delivery systems for natural products, increasing the stabil-
ity and solubility of loaded drugs and, thus, making them 
suitable for the administration. These nanostructures are 
also able to improve the biodistribution, with a consequent 
increased efficacy, as well as to favour the accumulation at 
target sites, reducing the adverse effects. Furthermore, the 
selection of biocompatible nanomaterials allow to decrease 
the formulation toxicity.
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